AIRWAY VISTA
Home > Activities > AIRWAY VISTA
Airway Vista is hosted by the Clinical Research Center for Chronic Obstructive Airway Diseases that has been supported by the Asan Medical Center,
Seoul and by the Ministry of Health & Welfare, South Korea. Since 2008, we have successfully held the Airway Vista annually which had more than
fifteen speakers and audience of approximately three hundreds. The scientific program of the symposium includes the most significant advances
in the researches of chronic airway diseases, COPD and asthma. We are contacting several world-renowned speakers, who are leading researchers
in the field of COPD and asthma in the world. The participants of the Symposium will be given the opportunity to share cutting-edge knowledge
in chronic obstructive airway diseases. In the symposium, new horizons in the understanding of chronic obstructive airway diseases, COPD and asthma,
will be expanding especially for pathogenesis, diagnosis, and treatment of COPD and Asthma.
▶Visit Website
Introduction
Airway Vista is hosted by the clinical research center for chronic obstructive airway diseases that has been supported by the asan medical center, seoul and by the ministry of health & welfare, south korea. since 2008, we have successfully held the airway vista annually which had more than twenty-five speakers and audience of approximately five hundreds.
This academic occasion aims to provide respiratory professionals with new horizons in understanding chronic obstructive airway diseases, COPD and asthma. It is our belief that it assures to be a premier forum for generating thought-provoking discussion on pathogenesis, evaluation, imaging, systemic aspects, exacerbation, heterogeneity, and new treatments of the ailment.
Program Overview
March 23(SAT), 2024 | |||
09:00-09:05 | Welcome Message from Chairman of Obstructive Lung Disease Research Foundation | ||
09:05-09:10 | Congratulatory Message from the President of the Korean Academy of Asthma, Allergy and Clinical Immunology |
Grand Auditorium | |||
Plenary Session: GINA, GOLD, and More (English) - Yeon-Mok Oh | |||
09:10-09:35 | Helen K. Reddel: Global Strategy for Asthma Management | ||
09:35-10:00 | Gerard Criner: GOLD Update 2024 (Virtually) | ||
10:00-10:25 | Gerard Criner: Interventional Treatments for COPD (Virtually) | ||
10:25-10:45 | Yeon-Mok Oh: Lung Regeneration Strategies for the Treatment of Emphysema | ||
10:45-11:00 | Break |
Grand Auditorium | Auditorium | ||
Precision Medicine (English) - An Soo Jang | COPD (Korean) - Sei Won Lee | ||
11:00-11:20 | Ian Adcock: Radiomultiomics: Linking Cellular Function to HRCT Imaging | 11:00-11:25 | Hyun Woo Lee: Emerging Pharmacologic Therapies on the Horizon of COPD Treatment |
11:20-11:40 | Fan Chung: The Variegate Molecular Endotypes of Severe Asthma from U-BIOPRED | 11:25-11:50 | Se Hee Lee: Microbiome Matters: Current Understanding and Future Prospects in COPD |
11:40-12:00 | Helen K. Reddel: Towards Precision Medicine in Asthma and COPD | 11:50-12:15 | Jieun Kang: Guidance for Managing Air Pollution Exposure in Patients with COPD |
12:00-12:20 | Sun Kim: Gene-level Biomarker Discovery from Multi-Omics Data Using Graph ATtention Neural Network for Asthma | 12:15-12:40 | Chiwook Chung: Recent Approaches of Digital Therapeutics in COPD - Impending Transformation |
12:20-12:40 | Philip Bardin: Real-world Evidence for OCS Reduction Using Biological Therapies in Severe Asthma - the Role of OCS Stewardship (Sponsored by GSK) | ||
12:40-13:50 | Lunch Break |
Discussion on hot issues of COPD and Asthma (English) - Sei Won Lee/Heung Woo Park |
Asthma (Korean) - Jaechun Lee | ||
---|---|---|---|
13:50-14:15 | Jieun Kang(Hye Yun Park/Ji Ye Jung): COPD Etiotypes and their Implication | 13:50-14:15 | Min Hye Kim: Clinical Predictors of Treatment Response to Tiotropium Add-on Therapy in Adult Asthmatic Patients: From Multicenter Real-world Cohort Data in Korea |
14:15-14:40 | Sungho Won(Woo Jin Kim/Jin Hwa Lee): How can we detect COPD-G and stratify the Risk of it for the Development and Progression of COPD | 14:15-14:40 | Ga Young Ban: Biomarkers in Aspirin-exacerbated Respiratory Disease |
14:40-15:05 | Mi-Ae Kim(Ji-Yong Moon/Taehoon Lee): Asthma Remission: Is it an Achievable Goal or not? | 14:40-15:05 | Han Ki Park: What Happen to the Gut Mucosal Immunity and Gut Microbiota in Patients with T2 Asthma? |
15:05-15:30 | Sae Hoon Kim(Jae-Woo Kwon/Sang Min Lee): Non-eosinophilic Asthma : Clinical Issues for Optimizing Management | 15:05-15:30 | Hyun Lee: How to Evaluate and Treat Patients with Both Asthma and Bronchiectasis |
15:30-15:45 | Break |
Novel Concepts in the Mechanism of Airway Diseases (English) - You Sook Cho | |
---|---|
15:45-16:05 | Ian Adcock: The Role of IL-33 in Non-T2 Obstructive Lung Disease |
16:05-16:25 | Fan Chung: The Microbiome of Severe Asthma: Importance of Bacterial Species Overgrowths |
16:25-16:40 | Break |
Molecular Subtyping of Asthma in COREA : RNA-seq Based Clustering Approach – Tae-Bum Kin/Fan Chung |
|
---|---|
16:40-16:50 | Duong Duc Pham: Interesting Clinical Findings from PRISM Study |
16:50-17:00 | So-Young Park: Molecular Phenotyping of Asthma Using Serum Transcriptomics in COREA |
17:00-17:10 | Jin An: Mucin and Biologics : Findings from Pre and Post CT Scans |
17:10-17:20 | Ga Young Ban: Multi-omics Meta Analysis for Asthma Clusters |
17:20-17:30 | Ji-Hyang Lee: scRNA Sequencing Reveals Hidden Secrets in Biologics Therapy |
17:30-17:40 | Han Ki Park: EV based Microbiome Biomarkers in Severe Asthma Patients Treated with Biologics: EBC and Stool |
17:40-17:45 | Closing |
Speaker